

Phares has developed in depth know-how and patents related to the formulation of poorly soluble compounds. Solubilization and bioavailability improvement are key goals of the formulation techniques. Phares has expertise and solutions for oral, parenteral and topical delivery.
Phares delivers the right level of service for each stage of pharmaceutical development. Our skills range from lead compound selection, through preclinical development, to the scaling up and manufacturing of cGMP supplies for human clinical trials.
Phares’ formulators are experienced industrial pharmacists, with decades of cumulative experience working on insoluble compounds. This translates into an expert understanding of the real requirements of preclinical and clinical development, as well as cGMP and the importance of regulatory acceptability of excipients and manufacturing processes.
BioPharm America
Atlanta, Georgia
September 9-10, 2008
AAPS
Atlanta, Georgia
November 16-20, 2008
BIO-Europe
Mannheim/Heidelberg, Germany
November 17-19, 2008